Special Reports
Hematologic Malignancies: Multiple Myeloma
Volume: 2
Issue: 2
Breast Cancer (Issue 2)
Volume: 1
Issue: 2
NSCLC (Issue 9)
Volume: 9
Issue: 4
Melanoma (Issue 5)
Volume: 5
Issue: 2
Prostate Cancer (Issue 1)
Volume: 1
Issue: 1
NSCLC (Issue 8)
Volume: 8
Issue: 3
Precision Medicine
Volume: 2
Issue: 1
NSCLC (Issue 7)
Volume: 7
Issue: 2
Genitourinary (Issue 2)
Issue: 2
Gastrointestinal Cancers (Issue 5)
Volume: 4
Issue: 2
Melanoma (Issue 4)
Volume: 4
Issue: 1
Immunotherapy (Issue 5)
Volume: 5
Issue: 1
Gastrointestinal Cancers (Issue 4)
Volume: 4
Issue: 1
NSCLC (Issue 6)
Volume: 6
Issue: 1
Head and Neck Cancers (Issue 3)
Volume: 3
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
5
